Company intelligence / Profile preview
Eli Lilly and Company
Indianapolis, Indiana, United States
- Ownership
- Public · PNT
- Employees
- ~47000
- Development stage
- Commercial
01
Overview
Eli Lilly & Co. is one of the world’s largest pharmaceutical companies with over $45 billion in annual revenue. It leads global markets in metabolic disease therapies—especially type 2 diabetes and obesity—with blockbuster drugs like Mounjaro/Zepbound (tirzepatide). The company also markets leading treatments for depression/anxiety disorders and maintains an extensive clinical pipeline focused on obesity/metabolic diseases, neuroscience/CNS disorders, immunology/inflammation, oncology/cancer therapeutics. Recent years have seen discontinuation of some Alzheimer’s/tau-targeting assets after failed trials but continued expansion in obesity/metabolic programs with at least eleven candidates under development.[6][9]
- Therapeutic areas
- OncologyEndocrinologyPsychiatryNeurology
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)PeptidesBiosimilarsRecombinant proteins (notably insulin products)
- Industry
- Pharma
02
Drug pipeline
508 assets507 more assets in the full pipeline.
Request access →03
Partnerships
University of Toronto for insulin production,[4]KeyBioscience AG for DACRA compounds,[9]numerous academic collaborations worldwideRecent extension with KeyBioscience AG on amylin/calcitonin receptor agonists.[9]
Beyond the preview
Go deeper on Eli Lilly and Company.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eli Lilly and Company.